Anthony Welters insider trades: Gilead Sciences (GILD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anthony reports to the SEC
and 2 more companies
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | GILD | ↓ Sell | 18,000 | $148.62 | $2.7M | Direct | Aug 27, 2026 (1d) |
| Mar 3, 2025 | L | ↓ Sell | 1,197 | $86.87 | $104K | Direct | Mar 4, 2025 (1d) |
| Dec 2, 2024 | L | ↓ Sell | 1,146 | $86.81 | $99K | Direct | Dec 3, 2024 (1d) |
| Sep 3, 2024 | L | ↓ Sell | 1,088 | $81.41 | $89K | Direct | Sep 4, 2024 (1d) |
| Jun 3, 2024 | L | ↓ Sell | 963 | $75.80 | $73K | Direct | Jun 4, 2024 (1d) |
| Mar 1, 2024 | L | ↓ Sell | 951 | $75.01 | $71K | Direct | Mar 4, 2024 (3d) |
| Dec 1, 2023 | L | ↓ Sell | 715 | $70.16 | $50K | Direct | Dec 4, 2023 (3d) |
| Feb 16, 2016 | BCR | ↓ Sell | 1,784 | $187.47 | $334K | Direct | Feb 18, 2016 (2d) |
| Dec 2, 2015 | L | ↑ Buy | 3,000 | $38.31 | $115K | Direct | Dec 4, 2015 (2d) |
| Dec 2, 2015 | CG | ↑ Buy | 25,000 | $17.77 | $444K | Direct | Dec 3, 2015 (1d) |
| Feb 9, 2015 | BCR | ↓ Sell | 1,563 | $169.02 | $264K | Direct | Feb 11, 2015 (2d) |
| Aug 12, 2013 | WST | ↓ Sell | 19,200 | $78.43 | $1.5M | Direct | Aug 14, 2013 (2d) |
| Jul 26, 2013 | BCR | ↓ Sell | 5,600 | $113.12 | $633K | Direct | Jul 30, 2013 (4d) |
| Apr 23, 2012 | UNH | ↓ Sell | 90,571 | $59.07 | $5.3M | Direct | Apr 24, 2012 (1d) |
| Mar 8, 2012 | UNH | ↓ Sell | 30,000 | $55.54 | $1.7M | Direct | Mar 9, 2012 (1d) |
| Feb 23, 2012 | WST | ↓ Sell | 9,000 | $42.61 | $384K | Direct | Feb 24, 2012 (1d) |
| Feb 13, 2012 | UNH | ↓ Sell | 76,000 | $53.58 | $4.1M | Direct | Feb 14, 2012 (1d) |
| Feb 3, 2012 | BCR | ↓ Sell | 4,800 | $93.23 | $447K | Direct | Feb 7, 2012 (4d) |
| Dec 14, 2011 | UNH | ↓ Sell | 18,254 | $48.16 | $879K | Direct | Dec 15, 2011 (1d) |
| Jul 26, 2011 | UNH | ↓ Sell | 21,025 | $52.00 | $1.1M | Direct | Jul 27, 2011 (1d) |
| Dec 9, 2010 | UNH | ↓ Sell | 97,500 | $36.51 | $3.6M | Direct | Dec 10, 2010 (1d) |
| Apr 28, 2010 | BCR | ↓ Sell | 2,400 | $86.46 | $208K | Direct | Apr 29, 2010 (1d) |
| Feb 23, 2009 | WST | ↓ Sell | 5,250 | $30.90 | $162K | Direct | Feb 24, 2009 (1d) |
| Feb 6, 2009 | BCR | ↓ Sell | 2,400 | $87.08 | $209K | Direct | Feb 9, 2009 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GILD insiders
Open-market trades in the last 12 months
About Anthony Welters's insider trades
Anthony Welters is a director at Gilead Sciences (GILD). Since Feb 6, 2009, Anthony has reported 2 open-market purchases worth $559K and 22 sales worth $23.9M on SEC Form 4. In the last 12 months: 1 sale ($2.7M).
Their filings also include grants and awards (201 filings), option exercises (33 filings), shares withheld for taxes (23 filings), gifts (15 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GILD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.